CD14 and gastric cancer: Individuals harbouring the CD14 -260 T allele (OR: 0.62, 95% CI: 0.42–0.91) and TT genotype (OR: 0.37, 95% CI: 0.16–0.82) were found to be significantly protected against the development of GC.